Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering

Annals of Oncology

Volumn 17, Issue 6, 2006, Pages 885-887

  Cherny, N I ^a   Catane, R ^b   Kosmidis, P A ^c,d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HYGEIA HOSPITAL   (Greece)

^d ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADVANCED CANCER; ANALGESIA; CANCER PAIN; CANCER PALLIATIVE THERAPY; DRUG CONTROL; DRUG COST; DRUG LEGISLATION; DRUG USE; ECONOMIC ASPECT; EDITORIAL; EUROPE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; TERMINAL CARE; UNITED KINGDOM;

EUROPE; EUROPE, EASTERN; HEALTH SERVICES ACCESSIBILITY; HUMANS; NARCOTICS; NEOPLASMS; PAIN;

EID: 33646866318     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl073     Document Type: Editorial

References (7)

1. Opioids and Pain European Network (OPEN) of Minds. The White Paper on Opioids and Pain: A Pan-European Challenge 2005.
2. The International Narcotics Control Board. Report 2004.
3. World Health Organisation. Achieving Balance in National Opioids Control Policy: Guidelines for Assessment. Geneva: World Health Organisation 2000.
4. Council of Europe. Recommendation Rec(2003)24 of the Committee of Ministers to member states on the organisation of palliative care and explanatory memorandum, 2003.
5. Cherny NI, Catane R. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: Report on a survey by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer 2003; 98: 2502-2510.
6. Cherny NI, Catane R, Kosmidis P. ESMO takes a stand on supportive and palliative care. Ann Oncol 2003; 14: 1335-1337.
7. Blunkett D, Reid J. Safer Management of Controlled Drugs: The Government's Response to the Fourth Report of the Shipman Inquiry. London: Her Majesty's Government 2004.